New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation
Summary: New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation
Summary: New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation